Avidity Biosciences Inc. (RNA)
Avidity Biosciences Max Pain By Strike
RNA trades at $46.46, 32.7% above the near-term max pain of $35 expiring Aug 15, 2025 (-1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($7-$45), reflecting growing call interest at higher strikes. High dispersion in max pain levels suggests competing forces and potential volatility.
Avidity Biosciences Max Pain By Expiry
Max pain for RNA shows an upward trend from 7 to 45, suggesting bullish positioning in longer-dated options. The 123% spread signals divergent expectations across timeframes. Most levels below 46.46 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 35 | -11.46 (-24.67%) |
| Sep 19, 2025 | 34 | -12.46 (-26.82%) |
| Oct 17, 2025 | 38 | -8.46 (-18.21%) |
| Dec 19, 2025 | 25 | -21.46 (-46.19%) |
| Jan 16, 2026 | 32 | -14.46 (-31.12%) |
| Mar 20, 2026 | 45 | -1.46 (-3.14%) |
| Dec 18, 2026 | 7 | -39.46 (-84.93%) |